Literature DB >> 809486

Modified counterelectrophoresis method for subtyping hepatitis B antigen.

M H Hatch.   

Abstract

A modified counterelectrophoresis (CEP) method was developed for determining the d and y subtypes of hepatitis B antigen (HBSAg). In this method, HBSAg of known subtype was diffused into the agarose gel before electrophoresis from the wells which were subsequently to receive the subtyping antiserum. This served to absorb the common anti-alpha antibody from the subtyping antiserum, which was heterologous with respect to the d or y component, during electrophoresis. The remaining d or y antibody then reacted type specifically with the antigen to be subtyped. The modified CEP method was much more sensitive than the immunodiffusion (ID) method for subtyping HBSAg. Sixty-two sera which could not be subtyped by ID were successfully subtyped by the CEP method. The geometric mean HBSAg complement fixation titer determined on 48 of these sera was significantly lower (P congruent to 0.016) than that of a group of sera which could be subtyped by ID. Sixteen other sera could not be subtyped by either the CEP or the ID procedure (geometric mean titer equal to 5.2). Therefore, more sensitive means of subtyping must be used for some HBSAg-positive sera.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809486      PMCID: PMC274176          DOI: 10.1128/jcm.2.3.231-234.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Specific inhibition of precipitation as an aid in antigen analysis with gel diffusion method.

Authors:  B BJORKLUND
Journal:  Proc Soc Exp Biol Med       Date:  1952-02

2.  Detection of additional antigenic determinants of hepatitis B antigen.

Authors:  W H Bancroft; F K Mundon; P K Russell
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

3.  Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis.

Authors:  P V Holland; R H Purcell; H Smith; H J Alter
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

4.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

5.  Relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody.

Authors:  N J Schmidt; P S Gee; E H Lennette
Journal:  Appl Microbiol       Date:  1971-08

6.  Subdeterminants d and y of hepatitis B antigen as epidemiologic markers.

Authors:  J W Mosley; V M Edwards; J E Meihaus; A G Redeker
Journal:  Am J Epidemiol       Date:  1972-06       Impact factor: 4.897

7.  Hepatitis B virus antigen: validation and immunologic characterization of low-titer serums with 125 I-antibody.

Authors:  C M Ling; H Irace; R Decker; L R Overby
Journal:  Science       Date:  1973-04-15       Impact factor: 47.728

  7 in total
  2 in total

1.  La Crosse virus soluble cell culture antigen.

Authors:  H S Lindsey; R A Klimas; J F Obijeski
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

2.  Determination of serum neutralization antibodies to rabies virus by a modified counterimmunoelectrophoresis test.

Authors:  A M Díaz; D M Myers
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.